Log In

Term Description

Newborn screening dried blood spot analysis by tandem mass spectrometry (MS/MS) requires pre-processing the specimen with one of two alternative reagent methods referred to as derivatized and non-derivatized (or underivatized) methods. The methods are similar and nearly all analytes and ratios are identical with the limited number of exceptions noted in the description of the LOINC codes. Some labs choose to use the non-derivatized method because it may be faster or less expensive for their operations. There are no analytes which would be interpreted differently based on the method used to process the specimen so there is no need for different LOINC codes for the same compounds based on the reagents. In a few cases, a different LOINC code is used for the derivatized or non-derivatized tandem mass spectrometry (MS/MS) method because based on the reagents used in processing, different analytes are measured or different sets of analytes become isobaric, which means that they cannot be distinguished on the MS/MS because they have the same molecular weight after reagent processing.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
57084-6Fatty acid oxidation newborn screen panelC
Indent46736-5Fatty acid oxidation defects newborn screen interpretationC
Indent57792-4Fatty acid oxidation conditions suspected [Identifier] in DBSC
Indent57709-8Fatty acid oxidation defects newborn screening comment-discussionC
Indent38481-8Carnitine free (C0) [Moles/volume] in DBSCumol/L
Indent53233-3Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
Indent53234-1Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBSC{Ratio}
Indent53235-8Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBSC{Ratio}
Indent53236-6Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBSC{Ratio}
Indent75211-3Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBSCumol/L
Indent75212-1Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{ratio}
Indent54462-7Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
Indent75213-9Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{ratio}
Indent50157-7Acetylcarnitine (C2) [Moles/volume] in DBSCumol/L
Indent53166-5Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBSCumol/L
Indent53167-3Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
Indent53168-1Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
Indent53169-9Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
Indent50102-33-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBSCumol/L
Indent45211-0Hexanoylcarnitine (C6) [Moles/volume] in DBSCumol/L
Indent53173-13-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBSCumol/L
Indent45207-8Glutarylcarnitine (C5-DC) [Moles/volume] in DBSCumol/L
Indent53174-9Octenoylcarnitine (C8:1) [Moles/volume] in DBSCumol/L
Indent53175-6Octanoylcarnitine (C8) [Moles/volume] in DBSCumol/L
Indent53176-4Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
Indent53177-2Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{Ratio}
Indent53178-03-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
Indent53402-43-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
Indent53179-83-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{Ratio}
Indent53180-6Decadienoylcarnitine (C10:2) [Moles/volume] in DBSCumol/L
Indent45198-9Decenoylcarnitine (C10:1) [Moles/volume] in DBSCumol/L
Indent45197-1Decanoylcarnitine (C10) [Moles/volume] in DBSCumol/L
Indent53182-23-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBSCumol/L
Indent53183-0Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBSCumol/L
Indent53403-2Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
Indent53184-8Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBSC{Ratio}
Indent53185-5Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
Indent53186-3Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
Indent45200-3Dodecenoylcarnitine (C12:1) [Moles/volume] in DBSCumol/L
Indent45199-7Dodecanoylcarnitine (C12) [Moles/volume] in DBSCumol/L
Indent53188-93-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBSCumol/L
Indent53189-73-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBSCumol/L
Indent53190-5Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBSCumol/L
Indent53191-3Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBSCumol/L
Indent53192-1Tetradecanoylcarnitine (C14) [Moles/volume] in DBSCumol/L
Indent53193-9Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
Indent53194-7Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBSC{Ratio}
Indent53195-4Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
Indent70159-9Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBSC{ratio}
Indent53196-23-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBSCumol/L
Indent53197-03-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBSCumol/L
Indent50281-53-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBSCumol/L
Indent53198-8Palmitoleylcarnitine (C16:1) [Moles/volume] in DBSCumol/L
Indent53199-6Palmitoylcarnitine (C16) [Moles/volume] in DBSCumol/L
Indent50121-33-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBSCumol/L
Indent50125-43-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBSCumol/L
Indent53201-03-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
Indent45217-7Linoleoylcarnitine (C18:2) [Moles/volume] in DBSCumol/L
Indent53202-8Oleoylcarnitine (C18:1) [Moles/volume] in DBSCumol/L
Indent53241-6Stearoylcarnitine (C18) [Moles/volume] in DBSCumol/L
Indent53400-8Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
Indent50109-83-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBSCumol/L
Indent50113-03-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBSCumol/L
Indent50132-03-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBSCumol/L
Indent53836-3ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

LOINC Names Get Info

Fully-Specified Name
Fatty acid oxidation newborn screen panel:-:Pt:Bld.dot:-:
Long Common Name
Fatty acid oxidation newborn screen panel
Short Name
FA oxidation NB scn pnl DBS
Display Name
Fatty acid oxidation NBS panel (DBS)
Consumer Name Alpha Get Info
Fatty Acid Oxidation NBS Panel, Dried blood spot

Part Model Get Info

  • Component
    Fatty acid oxidation newborn screen panel
    LP97000-1
    • Analyte
      Fatty acid oxidation newborn screen panel
      LP97000-1
      • Component Numerator
        Fatty acid oxidation newborn screen panel
        LP97000-1
        • Component Numerator Core
          Fatty acid oxidation newborn screen panel
          LP97000-1
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    Bld.dot
    LP21304-8
    • System Core
      Bld.dot
      LP21304-8
    • Super System
      NULL
       
  • Scale
    -
    LP7747-1
  • Method
    NULL
     

Basic Attributes

Class
PANEL.CHEM
Type
Laboratory
First Released
Version 2.29
Last Updated
Version 2.77 (PANEL)
Order vs. Observation
Order
Common Test Rank Get Info
17172
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
58092-8Acylcarnitine newborn screen panel
54089-8Newborn screening panel American Health Information Community (AHIC)

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Mastné kyseliny oxidace novorozenecký screening panel:-:Časový bod:Suchá krevní kapka (DBS):-:
el-GRGreek (Greece)Πίνακας εξετάσεων διαλογής οξείδωσης λιπαρών οξέων νεογνών:-:Pt:Bld.dot:-:
Synonyms: - Bld.dot CHEM PANEL.CHEM Pt Αίμα Οξείδωση λιπαρών οξέων Πίνακας εξετάσεων διαλογής οξείδωσης λιπαρών οξέων νεογνών
es-MXSpanish (Mexico)Panel de pantalla recién nacido de oxidación de ácidos grasos:-:Punto temporal:DBS:-:
es-ESSpanish (Spain)Panel de cribado de la oxidación de ácidos grasos en el recién nacido:Propiedades mixtas (sólo paneles):Punto temporal:gota de sangre (papel de filtro):-:
et-EEEstonian (Estonia)Rasvhapete oksüdatsioonidefektis sõeluuring vastsündinul:-:Pt:Vereplekk:-:
Synonyms: Juhuslik Veri
fr-FRFrench (France)Oxydation des acides gras dépistage néonatal panel:-:Ponctuel:Sang buvard:-:
fr-BEFrench (Belgium)Panel screening nouveau-né oxidation des acides gras:-:Temps ponctuel:Sang sur papier filtre:-:
it-ITItalian (Italy)Acidi grassi, panel di screening neonatale per ossidazione:-:Pt:Sangue.su carta da filtro:-:
Synonyms: Chimica Ossidazione degli acidi grassi Panel screening neonatale per ossidazione degli ac Punto nel tempo (episodio) Sangue Set di prescrizione chimica Spot sangue secco
nl-NLDutch (Netherlands)vetzuuroxidatie pasgeborene screening panel:-:moment:gedroogde bloedspot:-:
pl-PLPolish (Poland)Panel przesiewowy noworodka utleniania kwasów tłuszczowych:-:punkt w czasie:sucha kropla krwi:-:
pt-BRPortuguese (Brazil)Oxidação de ácidos graxos painel da tela de recém-nascido:#N/A:Pt:SgPapel:-:
Synonyms: ; FA oxidation NB scn pnl; FAO; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Scr; Scn; Scrn; Pnl; Pan; Panl; New born; Acd; Acids; PANEL.CHEMISTRY; PANEL.CHEMISTRY; Chemistry
ru-RURussian (Russian Federation)Жирные кислоты окисление новорождённый скрин панель:-:ТчкВрм:Кр.Сух.капл:-:
Synonyms: Кровь Кровь сухая капля Точка во времени;Момент
zh-CNChinese (China)脂肪酸氧化新生儿筛查组套:-:时间点:全血.斑点:-:
Synonyms: FAO 全血斑点(滤纸);滤纸;血液.斑点;血液斑点(滤纸) 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.化学试验;化学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;化学医嘱组类;医嘱组.化学;医嘱组.化学检验项目;医嘱组类.化学;医嘱组类.化学检验项目;医嘱组类.化学试验;实验室医嘱组类.化学;实验室医嘱组类.化学检验项目;实验室医嘱组类.化学试验 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 筛查 筛查试验 筛选试验 组 组合 组合医嘱 组合类 组套 脂肪酸氧化新生儿筛查组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;脂肪酸氧化功能新生儿筛查医嘱组;脂肪酸氧化新生儿筛查组套;脂肪酸氧化新生儿筛查组合 血;血液 过筛 过筛试验 酸

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=57084-6
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/57084-6